Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | CuttingEdgeInfo Reports | Diabetes Market Forecast to 2013 (TA221)

Diabetes Market Forecast to 2013 (TA221)

Comprehensive Diabetes Forecast

Which companies are poised to dominate the diabetes market? With new classes on the rise, which innovative therapies will make an impact? How will clinical results and safety issues affect drug profitability over the long term?

CEI’s veteran analysts answer these questions — and more — by placing critical drug information in a relevant industry-wide context. Other reports skim the surface, examining only top drugs at top companies. Ours is complete, covering marketed brands, pipeline products, clinical development, whole drug classes and top drug manufacturers — all in one, easy-to-read format.

From showing the most accurate sales projections and pipelines to identifying market threats and opportunities, “Diabetes Market Forecast to 2013” provides teams with a hard-hitting, penetrating analysis of the global diabetes market. For reliable evidence to support key resource allocation decisions, this is the only resource you’ll need.

Give your brand team all the diabetes data it needs to make critical product decisions!

Published 2008, 258 Pages, 51 Diabetes Product Profiles, 7 Company Portfolio Profiles
Table of Contents
Price: $9,995.00 / €6,686.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions